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Abstract 
Hypoxia is a state of lowered oxygen tension that can be created by environmental or pathological conditions. Regardless the origin 
of hypoxia, skeletal muscle cells adapt to deal with the acute or chronic reduction in oxygen availability. Although contrasting results 
have been reported as well, long lasting hypoxia generally leads to a negative regulation of protein balance and a loss of muscle 
mass, whereas intermittent hypoxia seems rather to exert a positive effect on muscle growth in the context of resistance exercise 
training. The purpose of the present review is to present the idea that chronic and acute hypoxia regulate skeletal muscle mass in 
two opposite ways. Chronic hypoxia-induced muscle atrophy in native highlanders, climbers or patients suffering from chronic 
obstructive pulmonary disease was previously thought to be caused by less calories ingested and reduced physical activity. More 
and more evidence is accumulating showing that hypoxia itself contributes to the loss of muscle mass during chronic exposure. In 
contrast repeated acute hypoxic sessions have the potential to slow down muscle atrophy and even to stimulate muscle mass 
accretion when coupled to resistance exercise as is the case with occlusion training. Further investigation should now focus on the 
molecular mechanisms by which acute and chronic hypoxia regulate skeletal muscle mass. Particular attention should be paid to 
satellite cells, which can be activated by hypoxia in-vitro. 
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Introduction 
Hypoxia is a state of low oxygen tension (PO2) created either by 
environmental conditions like high altitude exposure, or by 
pathological conditions such as chronic obstructive pulmonary 
disease (Baldi et al., 2010), obstructive sleep apnea (Garvey et 
al., 2009) or severe anemia (Grocott et al., 2007). During 
exercise, hypoxia can also occur, but contrary to the previous 
situations, oxygen restriction is in this case limited to skeletal 
muscle (Richardson et al., 2001). Regardless of the origin of 
hypoxia, skeletal muscle cells adapt to deal with acute or 
chronic reduction in oxygen availability. For example, patients 
exposed to chronic hypoxemia due to lung disease show 
muscle wasting and a higher 5 yr mortality rate (Schols et al., 
2005). Several studies have also revealed that highlanders and 
hikers undergo reductions in muscle fiber cross sectional area 
(Hoppeler et al., 1990; MacDougall et al., 1991; Mizuno et al., 
2008). Although contrasting results have been reported as well 
(Green et al., 2000; Lundby et al., 2004), long lasting hypoxia 
generally leads to a negative regulation of protein metabolism 
and a loss of muscle mass whereas acute hypoxia seems to 
rather exert a positive effect on protein balance in human 
(D'Hulst et al., 2013; Nishimura et al., 2010; Loenneke et al., 
2012). 
The purpose of this review is to present the idea that chronic 
and acute hypoxia regulate skeletal muscle mass in two distinct 
ways (Fig. 1). This hypothesis is based on the recent literature, 
although not in an exhaustive way, which was beyond the aim of 
the present manuscript. Before developing this idea further, the 
concepts of chronic and acute hypoxia must be defined. The 
term “chronic hypoxia” will be used for hypoxic conditions lasting 
for several days, whereas “acute hypoxia” will be used for a 
period of several hours. Another important point to rise initially is 
the difference between normobaric and hypobaric hypoxia. 
Extrapolating the results obtained in normobaric hypoxic 
chambers to altitude situations must be done with caution 
because hypobaric hypoxia seems to be a more severe 
environmental condition than normobaric hypoxia (Millet et al., 
2012). However, the regulation of protein metabolism has not 
been compared under both conditions. Therefore, it is currently 
difficult to know whether hypobaric hypoxia affects muscle mass 
more than normobaric hypoxia. Importantly, ambient hypoxia 
reduces skeletal muscle oxygenation, which could contribute to 
the activation of intracellular signaling leading to a deregulation   
of balance between protein synthesis and protein breakdown. 
Exposition to hypoxia (FiO2 10%) has been shown to reduce 
skeletal muscle oxygen tension from ~50mmHg to ~20mmHg in 
mice (Reinke et al., 2011) and from ~35mmHg to ~25mmHg in 
human (Richardson et al., 2006). Definitely, if the enhancement 
of protein balance by acute hypoxia exposure is confirmed by 
future studies, resistance exercise performed in conditions of 
reduced oxygen availability could become extremely useful not 
only for athletes looking for an improvement of performance due 
to increased muscle mass, but also for patients suffering from 
muscle wasting. 
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Figure 1. Regulation of muscle mass by acute and chronic hypoxia. Protein turnover is increased during chronic hypoxia, with protein breakdown 
being elevated to a greater extent than protein synthesis, resulting in a loss of muscle mass. In addition, an increase in inflammation and a decrease 
in physical activity, sleep duration/quality and appetite may all contribute to the catabolic state observed during chronic hypoxia. In contrast acute 
hypoxic sessions have the potential to slow down muscle atrophy and even to stimulate muscle mass accretion when coupled with resistance 
exercise possibly by increasing growth hormone production and satellite cell activation. 
Chronic hypoxia: Native highlanders and high 
altitude climbers 
Reduction in muscle mass is a common feature of native 
highlanders residing at altitude (Fiori et al., 2000), lowlanders 
exposed to low atmospheric oxygen conditions for more than 3 
weeks (Rose et al., 1988), and patients suffering from lung 
diseases (Schols et al., 2005). The first studies looking at 
muscle atrophy during chronic hypoxia were performed in 
climbers after a Himalayan expedition above 5000m for 8 weeks 
(Hoppeler et al., 1990) and in experimental subjects after 40 
days exposure to hypoxia in a hypobaric chamber (MacDougall 
et al., 1991). Hypoxic exposure was associated with skeletal 
muscle atrophy, and increased capillary density, which may 
support a more favorable oxygen transport to the muscle cells 
by decreasing the diffusion distance between blood and 
mitochondria. While muscle atrophy could be a consequence of 
hypoxic exposure per se, very high altitude expeditions are also 
associated with reduction in appetite, sleep deprivation. Also in  
low temperatures (Kayser, 1994), and in hypobaric chambers 
the limited space available may be associated with detraining 
atrophy. Thus, it is unclear whether muscle atrophy and the 
increase in capillary density are caused by hypoxia or by 
confounding factors. For example, a 21-day expedition to Mont 
Denali, did not induce any significant change in mean muscle 
fiber area (Green et al., 2000). Those results were confirmed in 
active Danish subjects exposed to 4100m for 8 weeks in the 
surroundings of La Paz in Bolivia (Lundby et al., 2004). It is thus 
tempting to state that a certain level of physical activity is critical 
in maintaining muscle mass under moderate hypoxia. To test 
this hypothesis, skeletal muscle adaptations were studied in 
very active climbers as well as in less active staff members at 
the base camp of Mount Everest at 5250m. Because the fiber 
size decreased to the same extent in both groups, the authors 
concluded that high altitude-associated weight loss is mainly the 
result of muscle fiber atrophy and that muscle wasting is 
independent of activity level (Mizuno et al., 2008). While muscle 
fiber atrophy at altitude above 4500m seems unavoidable 
(Hoppeler et al., 1990;MacDougall et al., 1991;Mizuno et al., 
2008), muscle fiber area can be preserved at lower altitudes if 
physical activity and diet are properly maintained (Green et al., 
2000;Lundby et al., 2004). 
The mechanisms regulating muscle mass in humans during 
long-term expeditions at high altitude are still poorly understood, 
but recent animal studies give further insight into the anabolic 
and catabolic processes in response to chronic hypoxic 
conditions in-vivo (Chaillou et al., 2012;Chaudhary et al., 
2012;Chaillou et al., 2013a;Favier et al., 2010). Male rats 
exposed for several days to hypobaric hypoxia (7620m) lost up 
to 30% of muscle mass (Chaudhary et al., 2012). This was 
associated with a higher protein turnover assessed by an 
increase of both protein synthesis and degradation. However, 
the increase in protein degradation was much higher than 
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protein synthesis (5-fold vs 1.5-fold), resulting in skeletal muscle 
loss. In another study wherein male rats were exposed to 
hypobaric hypoxia (6300m) for 3 weeks, muscle mass was 
decreased by about 15%. Considering the decreased muscle 
mass in a pair-fed group exposed to normoxia, the authors 
concluded that 60% of the muscle loss observed in hypoxia was 
independent of hypophagia (Favier et al., 2010). This 
observation was also in good agreement with previous data 
showing that increasing dietary protein intakes in rats is not able 
to reduce muscle loss related to high altitude exposure (Bigard 
et al., 1996). Favier et al. (2010) showed also that the decrease 
in muscle mass was accompanied by a marked increase in 
regulated in development and DNA damage responses (REDD1) 
expression and a down-regulation of the protein kinase B 
(PKB)/mechanistic target of rapamycin complex 1 (mTORC1) 
pathway, a key regulatory pathway of protein synthesis. 
Compared to male rats, females are more resistant to hypoxia 
(Wood and Stabenau, 1998) and are able to keep muscle mass 
unchanged after 8 weeks exposure to hypobaric hypoxia 
(5500m) (Chaillou et al., 2012). Still, hypoxia impaired partially 
and transiently the increase in plantaris muscle mass induced 
by removing the soleus and the gastrocnemius muscles as well 
as the increase in mTOR, ribosomal protein S6 kinase 1 (S6K1) 
and ribosomal protein S6 phosphorylations (Chaillou et al., 
2012). The repression of the PKB/mTOR pathway by hypoxia 
observed by Favier et al. (2010) and Chaillou et al. (2012) 
contrasts with the activation of protein synthesis measured by 
Chaudhary et al. (2012). At least two hypotheses may explain 
this apparent discrepancy: 1) Protein synthesis could be 
activated after a few days exposure to hypoxia (Chaudhary et 
al., 2012) and inhibited after several weeks (Chaillou et al., 2012; 
Favier et al., 2010); 2) indirect markers do not always reflect 
how protein synthesis is actually modified (Greenhaff et al., 
2008). 
Although not corroborated by everyone (Favier et al., 2010), 
chronic hypoxia seems to activate the ubiquitin-proteasome 
pathway as well as the calpains in rats (Chaillou et al., 2012; 
Chaudhary et al., 2012). The mRNA level of the two muscle-
specific ligases muscle ring finger protein-1 (MuRF-1) and 
muscle atrophy F box (MAFbx) (Chaillou et al., 2012) and the 
level of ubiquitinated proteins (Chaudhary et al., 2012) were 
increased after several days of exposure to hypoxia in rat 
skeletal muscle. Beside the ubiquitin-proteasome pathway and 
calpains, attention in a third proteolytic system, i.e. the 
autophagy-lysosomal pathway, was increasing (Tanida, 2011; 
Bonaldo and Sandri, 2013). The ubiquitin-proteasome pathway 
and autophagy-lysosomal pathway are under control of, 
amongst others, the forkhead box protein O (FoxO) transcription 
factors, which themselves are regulated by PKB. Whereas 
autophagy clearly plays an important role in skeletal muscle 
degradation, this process has only been investigated indirectly 
in skeletal muscle during hypoxia via lipofuscin release, which 
reflects membrane damage (Martinelli et al., 1990). 
Using two-dimensional difference in gel electrophoresis and 
mass spectrometry techniques, De Palma investigated hypoxia-
induced changes in rat skeletal muscle (De Palma et al., 2007). 
Hypoxia-inducible factor 1 alpha (HIF-1α), a master regulator of 
the hypoxic response (Semenza, 2011), and pyruvate 
dehydrogenase kinase 1 (PDK1) expression was up-regulated 
after 2-week normobaric hypoxia (FiO2 10%) whereas no 
modification of total mTOR was observed. Those results 
contrast with data obtained with a similar protocol and the same 
analytical techniques in humans where a slight decrease in total 
mTOR was found after 7-9 days at 4559m without any change 
in HIF-1α and PDK1 (Vigano et al., 2008). Only one study 
measured the protein synthesis and degradation rates after 
several days of adaptation to hypoxia (Holm et al., 2010). At rest, 
the whole body degradation rate was higher at 4559m altitude 
compared to sea level, but the synthetic rate remained similar. 
Interestingly, at the muscle level, the myofibrillar fractional 
synthetic rate was elevated by high altitude-induced hypoxia 
whereas the sarcoplasmic subfraction remained unaffected 
(Holm et al., 2010). In addition to activate HIF-1α, hypoxia could 
induce some physiological adaptations via an increase in 
reactive oxygen species (Clanton, 2007), although this is still 
controversial (Clanton, 2005). As reactive oxygen species 
contribute to muscle disuse atrophy (Powers et al., 2005), it 
would be worth to further investigate whether reactive oxygen 
species mediate hypoxia-induced muscle loss. 
All together those results show that chronic hypoxia induces 
muscle atrophy preferentially by accelerating protein 
degradation in healthy people (Table 1). In some cases, protein 
synthesis, and more particularly the myofibrillar fraction, can be 
increased too, leading to a higher protein turnover. However, 
the increase in protein degradation being much higher than the 
increase in protein synthesis, protein balance is negative during 
chronic hypoxia, which can lead to muscle loss over time. 
Chronic obstructive pulmonary disease 
Several interesting parallels and differences exist between 
chronic exposure to high altitude in healthy humans and chronic 
hypoxia in chronic obstructive pulmonary disease (COPD) 
patients (Raguso et al., 2004). Both may induce a decreased 
physical fitness, a loss of appetite, an increased oxidative stress 
and an increased production of cytokines, all factors known to 
favor a negative net protein balance. Whole skeletal muscle 
cross-sectional area is ~25% lower in patients with COPD than 
in control subjects (Bernard et al., 1998), often due to a 
decrease in fiber cross-sectional area (Jagoe and Engelen, 
2003). This decrease in cross-sectional area affects mainly type 
II fibers (Whittom et al., 1998) although type I cross-sectional 
area may be affected as well (Gosker et al., 2002). In contrast to 
muscle of native highlanders or high altitude climbers, in which 
increased capillary density is observed (Hoppeler et al., 1990), 
in COPD patients the reduced muscle mass is not 
counterbalanced by a preservation of muscle capillaries (Jobin 
et al., 1998). 
In COPD patients, it is generally assumed that the balance is 
tilted toward reduced protein synthesis and enhanced protein 
degradation (Hussain and Sandri, 2013). However the precise 
mechanisms underlying this imbalance remain unclear. 
Activation of catabolic factors such as interleukin-6 and cortisol 
and inhibition of anabolic factors such as testosterone, 
dehydroepiandrosterone, and insulin-like growth factor I could 
be involved (Debigare et al., 2003). In addition, local factors, 
such as oxidative stress caused by increased reactive oxygen 
species, or systemic factors, such as; inflammation, malnutrition, 
corticosteroid therapy, inactivity, smoking, aging, and 
hypoxemia could contribute to muscle atrophy in COPD patients 
(Debigare et al., 2001). 
Well-known anabolic and catabolic signaling pathways were 
screened in skeletal muscle of COPD patients (Plant et al., 
2010). Compared to control individuals, skeletal muscle of 
COPD patients displayed an increase in MAFbx and neural 
precursor cell expressed developmentally down-regulated 
protein 4 (Nedd4), two ligases regulating ubiquitin-mediated 
protein degradation. However, myostatin, a negative regulator of 
muscle growth, MuRF-1 and the myogenic regulatory factors 
Myf5, myogenin, and MyoD were not differentially expressed. 
There were no differences in the level of phosphorylation of 
PKB, glycogen synthase kinase 3 beta (GSK3β), S6K1,  
inhibitor of nuclear factor-kappa B (NF-κB) alpha (IκBα), NF-
κBp65 or NF-κBp50, or gene expression of beclin-1 or 
microtubule- associated protein 1
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Table 1. Effect of chronic and acute hypoxia on protein metabolism in human skeletal muscle. 
 Protein synthesis Protein breakdown Net protein balance 
Chronic hypoxia    
High altitude  or ~  Negative 
COPD   Negative 
Acute hypoxia    
Single exposure  or ~ ? ? 
Single exposure + ex  (Etheridge, 2011) or  
(Imoberdorf, 2006) 
? ? 
Repeated exposure + ex  ? Positive 
COPD, chronic obstructive pulmonary disease; ex, exercise; , decrease;  increase; ? unknown or understudied.
light chain (LC3), suggesting that PKB signaling was not down-
regulated and the NF-κB inflammatory pathway and autophagy 
were not activated in skeletal muscle of COPD patients. 
Therefore muscle atrophy associated with COPD seems to 
result from the recruitment of specific regulators of ubiquitin-
mediated proteolytic pathways and inhibition of muscle growth 
(Plant et al., 2010). Although the relative contribution of hypoxia 
per se to those mechanisms is quite difficult to evaluate, 
comparing hypoxemic to non hypoxemic COPD patients may 
help to partially answer this issue. Compared to non hypoxemic 
COPD patients (PaO2 73 mmHg), hypoxemic patients (PaO2 54 
mmHg) presented a substantial decrease in phosphorylation of 
several intermediates of the PKB/mTORC1 pathway in skeletal 
muscle (Favier et al., 2010). These findings highlight the role of 
hypoxia per se in the down-regulation of an important regulatory 
pathway of protein synthesis. Whereas high altitude and COPD 
clearly lead to skeletal muscle wasting, it has long been 
unknown whether hypoxia per se contributed to this 
phenomenon. Based on the current literature, more and more 
evidence indicate that it is indeed the case. In addition, muscle 
loss can be aggravated by nutritional deficit, reduction in 
physical activity, inflammation and/or oxidative stress.  
Acute hypoxia: Hypoxia in-vitro  
In-vitro, it is commonly assumed that acute hypoxia inhibits 
muscle protein synthesis (Koumenis and Wouters, 2006) 
primarily by inhibiting mTORC1 via activation of the AMP-
activated protein kinase (AMPK) (Liu et al., 2006) and increased 
expression of REDD1 (Brugarolas et al., 2004). Endoplasmic 
reticulum (ER) stress and its downstream response, the 
unfolded protein response, is another mechanism that has 
recently been proposed to participate in the reduction of protein 
synthesis under hypoxia (Koritzinsky et al., 2006). In-vitro, 
hypoxia activates HIF-1α more consistently than in-vivo, 
probably because of the very high level of hypoxia used in cell 
cultures (0-2% O2). However, it is unknown whether HIF-1α is 
directly responsible for the decrease in protein synthesis 
observed in vitro as HIF-1α and the mTORC1 pathway have 
been shown to regulate each other (Greer et al., 2012;Lee et al., 
2009;Cam et al., 2010). On the other hand, hypoxia has also 
been shown to inhibit mTORC1 in a HIF-1α-independent way in 
cell cultures (Arsham et al., 2003). Whether these observations 
from cell cultures, where very low concentrations of oxygen are 
used, may be extrapolated to living organisms remains an open 
question. In addition, the standard conditions in which cells are 
usually grown (21% O2) should be considered as hyperoxic. 
Indeed, oxygen tension in human skeletal muscle approximates 
30-40 mmHg in normoxia (Richardson et al., 2006), which 
corresponds roughly to 5% O2 in cell culture. Therefore oxygen 
concentration should be lowered to ~5% to get physiological 
normoxic conditions. As a result, oxygen concentrations below 5% 
represent hypoxic conditions. 
Single exposure to hypoxia 
The results reported in-vivo and more particularly in human are 
less clear. Compared to normoxic conditions, breathing 
normobaric hypoxic air (FiO2 12%) in a post-absorptive state did 
not modify muscle protein synthesis at rest but blunted the 
increase in protein synthesis induced by exercise (Etheridge et 
al., 2011). Contrary to the observations in-vitro, the blockade 
seemed independent of the mTORC1 pathway since hypoxia 
did not modify the phosphorylation of S6K1 or the expression of 
REDD1 both at rest and after exercise (Etheridge et al., 2011). 
The combined effects of hypoxia and exercise were also studied 
via an original experimental design wherein a group of subjects 
climbed from 550m to 4559m by foot and another group was 
flown by helicopter (Imoberdorf et al., 2006). Muscle protein 
synthesis rate was measured in both groups at sea level and at 
altitude. In the air group, the rate of synthesis was not modified, 
whereas in the foot group, a 35%-increase in protein synthesis 
was measured 19-23hrs after the end of the exercise, 
suggesting that exercise is still able to activate muscle protein 
synthesis even in hypoxia, contrary to the findings of Etheridge 
et al. (2011). Both studies used similar techniques for 
measuring protein synthesis, in both studies the subjects were 
in a fasted state when the protein synthesis measurements 
were made and the levels of hypoxia were similar. The major 
difference is probably the timing of measurements after the 
beginning of exposure to hypoxia. In the study of Etheridge et al. 
(2011), the measure was made between the first and the third 
hour after the beginning of exposure to hypoxia whereas in the 
sudy of Imoberdorf et al. (2006) after one day at altitude. 
Conjointly, these results seem to indicate that exercise-induced 
protein synthesis could be rapidly decreased at the onset of 
hypoxic exposure and restored after one day. This hypothesis 
however should be verified experimentally. 
To the best of our knowledge, the study of D'Hulst et al. (2013) 
from our lab is the first to have systematically studied the effect 
of acute hypoxia (FiO2 11%) on anabolic and catabolic signalling 
pathways in human skeletal muscle at rest. Whereas markers of 
protein degradation were only marginally enhanced, PKB and 
S6K1 phosphorylation were higher in skeletal muscles of 
subjects exposed for 4h to normobaric hypoxia. Interestingly, 
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despite a decrease in blood SpO2 and tissue oxygenation index 
measured by near-infrared spectroscopy, HIF-1α expression 
remained unaltered at both the protein and mRNA level (D'Hulst 
et al., 2013). The latter suggested that other, perhaps systemic 
factors, were involved in the activation of intramuscular 
signaling. Two likely candidates are insulin and cortisol, 
previously shown to be altered during hypoxic exposure (Larsen 
et al., 1997). Whereas plasma cortisol concentration was not 
modified by hypoxia, insulin returned more slowly to basal level 
after a standardised breakfast in the hypoxic trial. Independently 
of an increase in glucose concentration, insulin was 2 fold 
higher at the end of the exposure to environmental hypoxia and 
could partially explain several observations we made at this time, 
i.e. higher phosphorylation of PKB and S6K1. Although we did 
not measure plasma catecholamines concentrations, it is 
possible that adrenaline contributed to the increase in insulin as 
adrenaline increases at high altitude (Mazzeo et al., 1994) and it 
regulates insulin secretion by the pancreas (Lacey et al., 1993). 
If high concentrations of adrenaline inhibit insulin secretion, in-
vitro studies showed that low concentrations (10 nmol/l) 
potentiate glucose-induced insulin secretion by isolated human 
islets of Langerhans (Lacey et al., 1993). Those concentrations 
correspond to physiological plasma levels reached after one-
day exposure to ~4300m altitude (Mazzeo et al., 1994). 
Nevertheless, the activation of insulin secretion by adrenaline 
observed in vitro was transitory and followed by a sustained 
inhibition of secretion (Lacey et al., 1993). Therefore, adrenaline 
could participate to the increase in plasma insulin levels in the 
first hours of exposure to hypoxia but other regulatory signals 
probably overrule the long-term inhibitory effect of adrenaline on 
insulin secretion. Indeed, the hypoxia-induced increase in 
insulin persists for several days, thereafter (15-21 days) the 
concentration returns to sea level values (Sawhney et al., 1991). 
In another study undertaken by our lab insulin concentrations 
were not modified during exposure to hypoxia (FiO2 11%), 
probably because of a different nutritional pattern and/or 
exposure duration, the phosphorylation of PKB and S6K1 was 
not different between normoxia and hypoxia (unpublished 
results). These observations reinforce the idea that insulin is 
likely a main mediator of acute hypoxia-induced phosphorylation 
of the PKB pathway. Whether the activation of the PKB 
signaling pathway positively regulates protein synthesis during 
acute hypoxia is difficult to establish. Unfortunately, protein 
synthesis was not measured directly in D'Hulst et al. (2013) and 
the results available in the literature are inconclusive. Resting 
protein synthesis is either decreased (Rennie et al., 1983) or 
unchanged (Etheridge et al., 2011; Imoberdorf et al., 2006) by 
acute hypoxia in humans, but never increased. This suggests 
that the increase in insulin concentration and the activation of 
the PKB signaling pathway are not sufficient to activate protein 
synthesis during acute exposure to hypoxia at rest. Clearly, data 
are lacking to determine whether the activation of the PKB 
signaling pathway induced by an acute exposure to hypoxia 
could be beneficial for protein synthesis while recovering in 
normoxia as it is the case in training programs based on 
repeated exposures to hypoxia. 
Repeated acute exposure to hypoxia 
One efficient way of creating local hypoxia is to use a cuff to 
restrict blood flow into the limbs. Occlusion training alone can 
limit muscle atrophy in case of muscle disuse and induce 
hypertrophy when coupled with resistance exercise (Loenneke 
et al., 2012). This can provide a unique beneficial mode of 
exercise in the clinical setting because it produces positive 
training adaptations, at an intensity equivalent to physical 
activity of daily life (10–30% of maximal work capacity) (Abe et 
al., 2006). Muscle hypertrophy has recently been shown to 
occur during exercise at an intensity as low as 20% of the one-
repetition maximum (1-RM) together with moderate vascular 
occlusion (Sumide et al., 2009). Blood flow restriction training 
has been shown to be quite beneficial to athletes (Takarada et 
al., 2000a), patients in postoperative rehabilitation (Takarada et 
al., 2000b), cardiac rehabilitation patients (Takano et al., 2005), 
and the elderly (Abe et al., 2010). For detailed information on 
the topic, the reader is referred to a recent meta-analysis 
(Loenneke et al., 2012). 
Physiologically, occlusion training results in several changes to 
the body, the main modification being local hypoxia. Metabolic 
by-product accumulation seems to be the primary mechanism 
underpinning the benefits seen with occlusion training. Whole 
blood lactate (Gentil et al., 2006;Takano et al., 2005), plasma 
lactate (Takano et al., 2005;Fujita et al., 2007), and muscle cell 
lactate (Kawada and Ishii, 2005;Kawada and Ishii, 2008) 
accumulation due to the restriction of blood flow results in 
increased growth hormone, which was previously shown to be 
stimulated by an acidic intramuscular environment (Takarada et 
al., 2000a). However, growth hormone does not necessarily 
lead to an accretion of muscle mass (Rennie, 2003). Evidence 
indicates that a low pH also stimulates sympathetic nerve 
activity through a chemoreceptive reflex mediated by 
intramuscular metaboreceptors and group III and IV afferent 
fibers (Victor and Seals, 1989). Kawada and Ishii (2008) found 
that 2 weeks of chronic occlusion in rats caused a fiber-type 
shift from slow to fast. They attributed this to the additional 
recruitment of large motor units and their associated type II 
fibers at the expense of rapid fatigue in slow oxidative fibers 
during blood flow restriction. 
Recent studies have shown increased protein synthesis 
following acute bouts of blood flow restriction training, 
accompanied by higher phosphorylation of the PKB/mTOR 
pathway (Fujita et al., 2007; Fry et al., 2010). In addition, 
expression of the proteolysis-related genes FoxO3a, MAFbx 
and MuRF-1, as well as the negative regulator of muscle mass, 
myostatin, were decreased 8hrs after an acute exercise bout 
with blood flow restriction (Manini et al., 2011). Similarly a 
decrease in the mRNA level of myostatin and an increase in the 
mRNA level of follistatin isoforms, growth and differentiation 
factor-associated serum protein 1 and MAD-related protein 
could contribute to muscle hypertrophy after 8 weeks of low-
intensity resistance exercise associated with moderate blood 
flow restriction (Laurentino et al., 2012). In contrast, mRNA 
expression of other myogenic- and proteolysis-related targets 
did not change or differ between occluded and non-occluded 
exercise conditions (Drummond et al., 2008;Manini et al., 2011). 
Blood flow restriction training alone/combined with low-intensity 
resistance exercise has been developed originally to improve 
pathological states. This kind of training has proven its efficacy 
in reducing muscle atrophy or even to induce muscle 
hypertrophy but the degree of hypertrophy is less than the level 
obtained by athletes with classical high-intensity (>70% 1-RM) 
resistance training (Loenneke et al., 2012). However practicing 
high-intensity exercise while occlusion is applied is not 
conceivable. As hypoxia is thought to play a major role in 
adaptations induced by blood flow restriction (Drummond et al., 
2008), it has been postulated that by placing the entire body in a 
hypoxic environment, such as a hypoxic chamber, muscle 
hypertrophy could be more efficiently and more broadly up-
regulated than with local occlusion (Nishimura et al., 2010). This 
hypothesis has been recently tested and refuted as training at 
the same intensity while breathing hypoxic air or with blood flow 
restriction results in similar increases in muscle cross sectional 
area and strength (Manimmanakorn et al., 2013). The 
advantage of using a hypoxic room is that high-intensity 
resistance protocols can be applied. High-intensity (70% 1-RM) 
training induced more muscle hypertrophy in subjects who 
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trained for 6 weeks in a hypoxic chamber (FiO2 16%, ~2000m) 
than those in normoxia without differences in rate of perceived 
exertion during training (Nishimura et al., 2010), contrary to 
blood flow restriction training (Loenneke et al., 2010). Muscle 
strength was significantly increased after 6 weeks of training in 
both normoxic and hypoxic groups but only in the hypoxic group 
after 3 weeks, suggesting that exposure to hypoxia accelerates 
the increase in muscle strength. Interestingly, muscle 
hypertrophy was not significant in the group exposed to hypoxia 
without exercising, indicating that hypoxia alone is insufficient to 
increase muscle strength or to induce muscle hypertrophy and 
that it must be combined with exercise to achieve these results 
(Nishimura et al., 2010). In addition, a threshold corresponding 
to ~4500m of altitude seems to exist above which hypoxia does 
not induce any superior hypertrophy following resistance 
training compared to normoxia (Friedmann et al., 2003). 
Definitely acute hypoxia induces different, if not opposite, 
muscle adaptations than chronic hypoxia. Anabolic signals are 
triggered by acute hypoxia such as insulin and growth hormone. 
However it is unknown whether they effectively contribute to the 
increase in muscle mass observed after repeated sessions of 
resistance exercise in hypoxia. Moreover, protein degradation 
has been neglected in acute hypoxia studies and deserves 
more attention in the future. 
Satellite cell activity and hypoxia 
In addition to protein turnover, cell turnover also participates to 
the regulation of muscle mass (Pallafacchina et al., 2012). 
Myonuclear accretion, i.e. increase in the number of myonuclei 
within the muscle fibers, takes place via proliferation and fusion 
of satellite cells, myogenic stem cells associated to skeletal 
muscle fibers and involved in muscle regeneration. Exercise is a 
well-known activator of satellite cells, and more particularly 
eccentric resistance exercise (Macaluso and Myburgh, 2012). 
On the contrary, satellite cells and myonuclei may undergo 
apoptosis during muscle atrophy. However, the later point is 
controversial and it is still debated whether myonuclear loss 
occurs in atrophying muscle. 
In-vitro, acute hypoxia is able to activate proliferation 
(Chakravarthy et al., 2001; Csete et al., 2001; Koning et al., 
2011; Urbani et al., 2012), to promote self-renewal (Liu et al., 
2012) and to inhibit differentiation of satellite cells (Gustafsson 
et al., 2005; Liu et al., 2012; Majmundar et al., 2012), although 
conversely activation of differentiation has also been shown 
(Kook et al., 2008). Interestingly short-term low-load resistance 
exercise performed with partial blood flow restriction was shown 
to result in marked proliferation of myogenic stem cells and 
myonuclei addition in human skeletal muscle, which was 
accompanied by substantial myofibre hypertrophy (Nielsen et al., 
2012). On the other hand, ambient hypoxia has been shown to 
reduce satellite cells activity and protein synthesis in rats, 
contributing to impaired formation and growth of new fibers and 
thereby to the accelerated muscle loss observed after extensive 
injury compared to normoxia (Chaillou et al., 2013b). Similar 
results have been found in skeletal muscle of climbers having 
stayed for 6 weeks above 5000m (Mancinelli et al., 2011). 
Satellite cells from muscle biopsies after high-altitude expedition 
showed a significantly lower ability to regenerate skeletal 
muscle probably due to reduced activity, decreased myogenicity 
and fusion ability. COPD patients with a reduced muscle mass 
have less centrally located nuclei as well as more senescent 
satellite cells than healthy subjects or patients with a preserved 
muscle mass (Theriault et al., 2012). These results suggest that 
an increase in damage/repair recurrence, possibly due to 
hypoxia, may exhaust the regenerative capacity of satellite cells 
in COPD patients with reduced muscle mass, leading to the 
senescence of satellite cells and muscle atrophy. The signaling 
pathways mediating the regulation of satellite cells in general 
are poorly described and even less is known about the 
regulation of satellite cells by hypoxia. Satellite cell activation is 
controlled by several growth factors, intracellular signaling 
pathways and transcription factors (Cassano et al., 2009) which 
preferentially regulate proliferation or differentiation of satellite 
cells. Insulin-like growth factor-1 is unique, in that it promotes 
both proliferation and differentiation. In contrast, satellite cell 
proliferation is impaired by inhibitory factors, such as myostatin 
and other transforming growth factor beta family members. The 
Notch and Wnt signaling pathways appear to have a major role 
in controlling the balance between satellite cell proliferation and 
differentiation (Brack et al., 2008). Whether hypoxia regulates 
the Notch pathway is controversial as some authors found 
increased activation (Gustafsson et al., 2005; Liu et al., 2012) 
and others no modification (Majmundar et al., 2012) under 
hypoxia. Gustafsson et al. (2005) propose a molecular model 
where HIF-1α and Notch intracellular domain form a point of 
convergence between the two signaling mechanisms, leading to 
stabilization of Notch intracellular domain, recruitment of HIF-1α 
to Notch-responsive promoters and activation of Notch 
downstream genes (Gustafsson et al., 2005). On the other hand, 
Majmundar et al. (2012) propose a mechanism involving the 
phosphatidylinositol 3-kinase/PKB pathway and independent of 
HIF-1α (Majmundar et al., 2012). The exact mechanisms by 
which hypoxia regulates satellite cells activation and 
differentiation are far to be elucidated and are probably a 
promising area of research. 
Conclusion 
Chronic hypoxia-induced muscle atrophy was previously 
thought to be caused by less calories ingested and reduced 
physical activity levels. More and more evidence accumulate 
showing that hypoxia itself contributes to the loss of muscle 
mass during chronic hypoxia. In contrast acute hypoxic sessions 
have the potential to slow down muscle atrophy and even to 
stimulate muscle mass accretion when coupled with resistance 
exercise. Further investigation should now focus on the 
molecular mechanisms by which acute and chronic hypoxia 
regulate skeletal muscle mass. Particular attention should be 
paid to satellite cells, which can be activated by hypoxia in-vitro.  
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